Expressionlines
Beauty, Essence of Well Being!
Home
Revision Skin Care
Kinerase
Specials
Skin Care Treatments
Skin Care Basic
Facials
Sun & Laser Burns
Puffy & Dark Under Eyes
Wrinkles & Expression Lines
IPL Photorejuvenation
Microdermabrasion
Smoking Speeds Up Aging
A Wrinkle In Time
Summer Skin Guide
Misconceptions about skin
UVA & UVB Rays and Aging
Aging and Myths
Dark Under Eye Circles
Coenzyme Q10: Anti-wrinkle protection
Spider Veins
Cellulite and Mesotherapy
Rosacea treatments
Fantastic Skin
Ms Beautiful Eyes
Chemical Peels
Strivectin SD Myth
Acne Scars & Treatments
Tanning Beds & Cancer
News
Testimonial
Store Policy
Contact Us
Shopping Cart

Strivectin SD


Quite a few of you have written asking about the rather prominent
newspaper ads for the product StriVectin-SD ($135 for 6 ounces). With a
headline that reads "Better than Botox," along with the increasing number
of topical products hitting the market claiming they can mimic the
effects of Botox without "painful injections," I certainly understand the
curiosity.

I wrote about StriVectin-SD in a previous newsletter, when a reader
asked about its ability to repair stretch marks. That was StriVectin's
original marketing claim to fame, though the fame was all self-promoted,
as there is not a single independent, peer-reviewed study to prove that
StriVectin is an effective option for repairing stretch marks. The
studies that do exist about StriVectin's benefits for stretch marks were
paid for by Klein-Becker, the company that distributes StriVectin.

According to the company's latest ads, they were surprised to find that
not only was StriVectin-SD getting rid of women's stretch marks, but
also that somehow their facial wrinkles were going away, too. For that
reason, we now have the astounding "anti-wrinkle breakthrough of the
decade." Regrettably, no supportive research needs to be available to sell
this kind of hyperbole. All it takes is to promise women that a product
will get rid of their wrinkles and they will buy it in droves, no
matter how many other product lines, infomercials, advertisements, or
cosmetics salespeople pledge the exact same thing.

StriVectin's ad continues with "The active formula in StriVectin-SD has
recently been shown in clinical trials to significantly reduce that
category of fine lines and facial wrinkles that can add 10–15 years to
your appearance...and even reduce the dark circles under your
eyes...without irritation, painful injections, or surgery." One more flourish is
the statement that "in fact, [StriVectin-SD] is the only topical
formulation clinically proven to effectively confront every aspect of wrinkle
reduction." It is easy to debunk all of this overblown nonsense by
pointing out the product's lack of sunscreen; perhaps StriVectin overlooked
the research about sun exposure's deleterious, wrinkling, and
discoloring effects on skin.

Klein-Becker has parlayed these claims into what appears to be little
more than an effort to spin off the popularity of Botox to its own
benefit. StriVectin-SD is supposedly preferred because its long-term results
versus the short-term results (and repeated treatments) of Botox. A Dr.
Nathalie Chevreau is quoted in the ad, saying "the cumulative effects
of using a product like StriVectin become more noticeable every day, and
ultimately last longer than Botox." Chevreau is hardly an impartial
source, as she works for Klein-Becker. Further, Dr. Chevreau is a licensed
dietician in Utah, a fact that is conveniently left out of StriVectin's
ad because it would conflict with her credibility as a medical doctor
speaking about the legitimate benefits of an antiwrinkle cream.

The final Botox comparison comes from the ad's statement that
StriVectin not only addresses the _expression lines Botox treats, but also the
lines Botox doesn't affect. However, the only lines Botox wouldn't
affect are the ones not injected.

Needless to say, Klein-Becker's statements comparing StriVectin-SD to
Botox have not gone unnoticed by Allergan, the company that manufactures
the drug. According to an article in The Salt Lake Tribune, Allergan
has threatened to sue Klein-Becker for false advertising and unfair
business practices. After the tension continued to mount on both sides,
Klein-Becker actually went ahead and took the case to court, asking a
federal judge to approve its advertising for StriVectin-SD. As this
newsletter goes to press, Klein-Becker has not taken their lawsuit any further.

In the meantime, the "Better than Botox" ads remain in wide circulation
and are sent via spam emails, and StriVectin-SD is now available at
Nordstrom department stores.

So is StriVectin better than Botox? The short answer is no--and that
means no way, and nohow. It isn't even better than the daily use of an
effective sunscreen! StriVectin is merely a moisturizer with some good
emollients and antioxidants, though the addition of peppermint oil is
extremely suspect--the tingle is probably meant to lead women to believe
that the product is doing something to their skin. Botox prevents the
use of facial muscles, and that instantaneously smoothes out the skin.
StriVectin-SD won't alter the wrinkling on any part of your face, not in
the long term, and not in the short term.

Incidentally, the two studies quoted in StriVectin's ads for "Better
than Botox" were supposedly from information presented at the 20th World
Congress of Dermatology, held in July 2002. These examined the effects
of palmitoyl pentapeptide-3 (trade name: Matrixyl, but also known as
Pal-KTTKS, which is the term used in StriVectin's ads) and compared it to
vitamin C and retinol. However, there is no published research
substantiating the results, and StriVectin declined to send us any
documentation.